Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Randomized Evaluation of Bone Ingrowth After Intervertebral Body Fusion With Either MectaLIF® PEEK or MectaLIF® TiPEEK Oblique"

NCT03063008 is registered in ClinicalTrials.gov with Mohammad ARAB MOTLAGH as lead sponsor.

NCT NCT03063008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03063008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Randomized Evaluation of Bone Ingrowth After Intervertebral Body Fusion With Either MectaLIF® PEEK or MectaLIF® TiPEEK Oblique"
Lead sponsor
Mohammad ARAB MOTLAGH
Phase
Not applicable
Overall status
Completed
Start date
January 16, 2012
Completion date
December 1, 2013
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vertebral fusion